The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Atezolizumab Trial as Adjuvant Therapy Targeting PDL1 After Nephrectomy M0

Supersum
Supersum CSN Member Posts: 109 Member
in Kidney Cancer #1

Roche is running a trial:

"A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy (IMmotion010)"

I have started on the trial and had my first infusion last week.

Read more and check locations here:

https://clinicaltrials.gov/ct2/show/NCT03024996

 

 

Like Care

Comments

  • Supersum
    Supersum CSN Member Posts: 109 Member
    #2
    Forgot to mention please ask

    Forgot to mention please ask me if you have any questions or just leave any general comments or advice, that would be great.

    Would also be great to hear from the other 663 participants in the trial to share notes  Smile

    Like Care

Discussion Boards